Horizon Therapeutics Public Limited Company: Revision history

20 August 2022

• curprev 02:4502:45, 20 August 2022 95.149.241.133 talk 1,849 bytes +11 No edit summary undo

13 August 2022

• curprev 02:1502:15, 13 August 2022 109.180.50.163 talk 1,838 bytes +15 No edit summary undo

7 August 2022

• curprev 16:0116:01, 7 August 2022 >Paris 1,823 bytes +1,823 Created page with "Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous inf..."